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Introduction
Multiresistant bacteria (MRB) development is a growing
phenomenon. In 2013, the “Zero Resistance” (RZ) program
was launched in Spain, to help prevent the emergence of
multiresistant bacteria (MRB) in critically ill patients. One of
its recommendations is to complete a checklist upon patient
admission in Intensive Care Unit (ICU) to identify those
patients at high risk for colonization or infection by MRB*.
Objectives
To search the relation between most common MRB and
specific risk factors for colonization and infection, and
the location of the samples where they are identified.
Methods
A prospective study from March 17th, 2014 to January
31rst, 2015. All patients admitted to a polyvalent ICU of a
general hospital were submitted to the checklist proposed,
with the application of contact precaution (CP) measures
in patients at risk for colonization or infection by MRB.
Bacteriologic swabs (nasal, pharyngeal, axillary and rectal)
were routinely performed to all patients admitted, besides
diagnostic cultures when needed. Furthermore, we ana-
lysed other pathological variables and comorbidities. The
difference between groups of MRB was made by Chi-
square test for qualitative variables and the Kruskal-Walls
test for the continuous ones. Statistical significance was
set at p < .05.
Results
In 78 patients were identified one or more MRB (in total
91 MRB). They were classified in 6 groups. 29 patients
(37,2%) were MRSA carriers, 22 (28,2%) E coli ESBLs,
10 (21,8%) Klebsiella spp ESBLs, 10 (12,8%) P aeruginosa,
8 (10,2%) Acinetobacter spp and 12 (15,4%) others MRB
carriers (including 1 case of carbapenemase). Nasal swabs
detected 26 (33,3%) of MRB carriers [22 (75,9%) of all
MRSA], pharyngeal swabs 26 (35,9%) [17 (43,6%) of
MRSA], axillary swabs 13 (16,7%) [7 (24,1%) of MRSA,
3 (37,5%) of Acinetobacter spp], and rectal swabs 30
(38,5%) [27 (87,1%) of ESBLs, 3 (37,5%) of Acinetobac-
terspp]. Diagnostic cultures (blood, urine, bronchoaspirate,
surgical wound and others) detected MRB in less than 30%
of the cases. The checklist did not detected neither coloni-
zation nor infection by MRB in 29 (37,2%) patients (44,8%
MRSA, 50% Acinetobacter spp, 38,7% of ESBLs). We did
not find significant relation with other comorbidities.
Conclusions
In our environment, we detected a predominance of
MRSA, higher than the Spanish media, followed by ESBLs.
MRSA carriers were identified mostly by nasal swabs
while the ESBL carriers were identified mainly by rectal
swabs. We did not find significant relation between BMR
and other comorbidities, possibly because of the sample
size. The RZ checklist did not identify almost 40% of
the MRB.
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